Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02813694 · ClinicalTrials.gov registry record · Phase 3

Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia

A Phase 3 study of Community-acquired Pneumonia, sponsored by Nabriva Therapeutics.

Completed
Registry status
Phase 3
Development phase
738
Enrollment target
20
Study locations

NCT02813694 is a Phase 3 study of Community-acquired Pneumonia that has completed, run by Nabriva Therapeutics. The registered enrollment target is 738 participants, below the 109,039-participant average among 9 other Community-acquired Pneumonia trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02813694, a Phase 3 study of Community-acquired Pneumonia, has completed, sponsored by Nabriva Therapeutics.

COMPLETED
Registry status
Phase 3
Development phase
738 participants
Enrollment target
20
Study locations

Study Summary

This study evaluates the safety and efficacy of lefamulin, a pleuromutilin, for the treatment of adults with moderate community-acquired bacterial pneumonia

Conditions Studied

Community-acquired Pneumonia

Interventions

  • DRUG Moxifloxacin
  • DRUG lefamulin

Study Locations (20)

California

  • 1080 - Beverly Hills
  • Site 1065 - Fresno
  • 1078 - Northridge
  • Site 1072 - Oxnard
  • Site 1070 - Sacramento
  • 1079 - Sherman Oaks
  • Site 1053 - Sylmar

Florida

  • Site 1064 - DeBary
  • Site 1052 - DeLand
  • 1076 - Miami

Michigan

  • Site 1055 - Detroit
  • Site 1062 - Detroit
  • Site 1068 - Royal Oak

Indiana

  • Site 1051 - Michigan City

Louisiana

  • Site 1057 - Natchitoches

Massachusetts

  • Site 1073 - New Bedford

Missouri

  • Site 1058 - St Louis

Montana

  • Site 1054 - Butte

Trial Details

FieldValue
Enrollment Target 738 participants
Start Date 2016-08
Est. Completion 2018-01
Phase Phase 3

Sponsor

Nabriva Therapeutics

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02813694

The ClinicalTrials.gov registry entry for NCT02813694 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 738 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,039-participant average among 9 other Community-acquired Pneumonia trials with a reported enrollment target (99% lower). The listed sponsor is Nabriva Therapeutics, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Community-acquired Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which Moxifloxacin is the first listed.

NCT02813694 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Florida, Michigan.

Frequently Asked Questions

What is clinical trial NCT02813694 about?

NCT02813694 is a clinical study titled "Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia". This study evaluates the safety and efficacy of lefamulin, a pleuromutilin, for the treatment of adults with moderate community-acquired bacterial pneumonia

What is the current status of trial NCT02813694?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 738 participants. The study started on 2016-08. Estimated completion is 2018-01.

What conditions does trial NCT02813694 study?

This clinical trial studies the following conditions: Community-acquired Pneumonia.

What interventions are being tested in trial NCT02813694?

The interventions under investigation include: Moxifloxacin (DRUG), lefamulin (DRUG).

Who is sponsoring clinical trial NCT02813694?

This trial is sponsored by Nabriva Therapeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02813694 being conducted?

This trial has 20 study locations across California, Florida, Indiana, Louisiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Community-acquired Pneumonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Community-acquired Pneumonia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.